Heron Therapeutics said its late-stage anesthetic used to treat bunionectomy and hernia repair hit all primary and key secondary endpoints in two Phase III trials that cut down on the…

Denali Therapeutics, located in South San Francisco, California, had a lot of news to share today. Source: BioSpace

Companies that have a strong focus on developing drugs that target messenger RNA (mRNA) may be ahead of the curve when it comes to potentially tapping into a lucrative market…

Arbor Biotechnologies came out of stealth mode yesterday with a $15.6 million Series A financing round. Source: BioSpace

There are dangers in biotech funding and Theranos should serve as a warning. Source: BioSpace

Tetra Discovery Partners announced that the FDA had given its Investigational New Drug application the go-ahead for Fragile X Syndrome and potentially other autism spectrum disorders. Source: BioSpace

Peggy Whitson has spent 665 days in space, more than any other US astronaut and more than any other female astronaut in the world. You don’t associate Peggy Whitson with…

Platinum Equity submitted a binding offer to Johnson & Johnson to buy LifeScan for $2.1 billion. Source: BioSpace

AMO Pharma reported that patients treated with its Phase II neuromuscular treatment for onset myotonic dystrophy type 1 experienced clinical benefits such as an improvement in cognitive function and an…

Adaptimmune reported it saw three partial responses in three of the four myxoid/ round cell liposarcoma (MRCLS) patients the company dosed with its NY-ESO SPEAR T-cells. Source: BioSpace